Pierre Feugier

Pierre Feugier

Université de Lorraine - Nancy / France
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4690608
University of Lorraine
person_outline Pierre Feugier's MOST POPULAR ARTICLES
1-) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’AdulteP Feugier, A Van Hoof, C Sebban, P Solal-Celigny, R Bouabdallah, ...J Clin Oncol 23 (18), 4117-4126, 200518012005
2-) Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trialG Salles, JF Seymour, F Offner, A López-Guillermo, D Belada, L Xerri, ...The Lancet 377 (9759), 42-51, 201111492011
3-) Treatment of older patients with mantle-cell lymphomaHC Kluin-Nelemans, E Hoster, O Hermine, J Walewski, M Trneny, ...New England Journal of Medicine 367 (6), 520-531, 20125782012
4-) Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patientsM Leporrier, S Chevret, B Cazin, N Boudjerra, P Feugier, B Desablens, ...Blood, The Journal of the American Society of Hematology 98 (8), 2319-2325, 20015552001
5-) Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort studyC Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ...The Lancet Infectious Diseases 17 (5), 510-519, 20175482017